Featuring the announcement of the new collaborative service GetFTR, advancements in European policies for open science and digital enhancements in medical publishing
Featuring persistent object identifiers for research organizations, an investigation into the standards of reporting randomized clinical trials, the co-production of scientific research and the development of the next set of Good Publication Practice guidelines.
Featuring the new read-and-publish deal between Elsevier and Carnegie Mellon University, a beta repository for research from UK cultural and heritage organizations and the range of APC across publishers
Featuring highlights from the ISMPP U webinar on plain-language summaries, lessons learned from the YODA Project and the benefits of Wiley’s ‘Under Review’ service.
Featuring the proposed concept of geowalling, highlights from World Science Day 2019, the Health Research Authority’s trip to the House of Commons and ISMPP’s support of the Open Pharma position statement.
Featuring the return of ‘Unreported clinical trial of the week’, exciting opportunities in the age of digital publishing and a new pilot to make comments on preprints publicly available
Today, just over two weeks from the launch of the Open Pharma position statement on open access, we reflect on how the statement came about, the benefits it offers to different types of stakeholders and the success it has had so far.
Featuring a sneak preview of responses to the Health Research Authority ‘Make it Public’ consultation, an investigation into researchers’ communication with study participants and the worldwide spread of endorsements for the Open Pharma position statement on open access
Last week was International Open Access Week covering the topic ‘Open for whom? Equity in open knowledge’. Open Pharma kicked off this year’s Open Access Week with the launch of its position statement on open access at a MedComms Networking event in Oxford on 21 October 2019. The statement calls for publishers to allow authors … Continue reading Find out what Open Pharma achieved during Open Access Week 2019
Featuring the launch of the Open Pharma position statement on open access, an introduction to the Open Science in Action Inaugural Symposium and a call to action for the UK government to do more to ensure transparent clinical trial reporting.